2014
DOI: 10.1371/journal.pone.0090688
|View full text |Cite
|
Sign up to set email alerts
|

Massively Parallel DNA Sequencing Facilitates Diagnosis of Patients with Usher Syndrome Type 1

Abstract: Usher syndrome is an autosomal recessive disorder manifesting hearing loss, retinitis pigmentosa and vestibular dysfunction, and having three clinical subtypes. Usher syndrome type 1 is the most severe subtype due to its profound hearing loss, lack of vestibular responses, and retinitis pigmentosa that appears in prepuberty. Six of the corresponding genes have been identified, making early diagnosis through DNA testing possible, with many immediate and several long-term advantages for patients and their famili… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
25
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 36 publications
(26 citation statements)
references
References 25 publications
1
25
0
Order By: Relevance
“…Similarly, multiple splice site mutations of the MYO7A gene have been reported previously [36], [56], [57], and two of those mutations were proved to alter the natural splicing through hybrid minigene assays [58]. In our case, in an attempt to understand the possible protein change resulted from c.1343+1G>A, we applied four online prediction software to evaluate the effect of c.1343+1G>A on splicing.…”
Section: Discussionmentioning
confidence: 77%
“…Similarly, multiple splice site mutations of the MYO7A gene have been reported previously [36], [56], [57], and two of those mutations were proved to alter the natural splicing through hybrid minigene assays [58]. In our case, in an attempt to understand the possible protein change resulted from c.1343+1G>A, we applied four online prediction software to evaluate the effect of c.1343+1G>A on splicing.…”
Section: Discussionmentioning
confidence: 77%
“…The remaining 35 patients had no function-affecting sequence variants identified before this investigation. The eight patients with two sequence variants in USH2A were included, as patients with three different function-affecting sequence variants located in two different genes 19,23 as well as patients with three different sequence variants located in the same gene, including USH2A, have been published previously. 15,24 The project was approved by the local ethics committee (H-3-2011-070) and carried out in accordance with the Declaration of Helsinki.…”
Section: Materials and Methods Patientsmentioning
confidence: 99%
“…[3][4][5][6][7][8][9][10][11][12][13][14][15][16] We applied MPS technology to (1) discover causative mutations in relatively rare causative genes 12,13 and (2) clarify the molecular epidemiology. [3][4][5][6][7][8][9][10][11][12][13][14][15][16] We applied MPS technology to (1) discover causative mutations in relatively rare causative genes 12,13 and (2) clarify the molecular epidemiology.…”
Section: Introductionmentioning
confidence: 99%
“…11,13,16,17 In the current study, on the basis of our PCR-based technologies in combination with MPS, 13,17 we increased the number of patients (1120 cases of nonsyndromic hearing loss) to establish a database for clinical molecular diagnosis and to confirm the molecular epidemiology of deafness. Hybridization-based capture is commonly used for genomic target enrichment, but for clinical application, polymerase chain reaction (PCR)-based technologies in combination with MPS have also been proposed.…”
Section: Introductionmentioning
confidence: 99%